Robinson Elliott 4
4 · Hinge Health, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Hinge Health (HNGE) Robinson Elliott Sells Shares
What Happened
- Robinson Elliott, a partner at Bessemer Venture Partners and reported 10% owner, filed a Form 4 disclosing sales of Hinge Health (HNGE) Class A stock by Bessemer-managed funds on Feb 17–18, 2026. The filing shows the sales were effected by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P., not Elliott personally.
- On Feb 17 the Bessemer Funds sold 46,276 and 43,440 shares (total 89,716) at a weighted average price of $39.929 (prices ranged $39.50–$40.31). On Feb 18 they sold 48,353 and 45,390 shares (total 93,743) at a weighted average price of $40.358 (prices ranged $39.535–$40.855). Combined sales ≈ 183,459 shares for roughly $7.36 million. Elliott disclaims direct beneficial ownership of the fund-held shares, noting only an indirect, passive pecuniary interest.
Key Details
- Transaction dates and prices: Feb 17, 2026 — weighted avg $39.929 (range $39.50–$40.31); Feb 18, 2026 — weighted avg $40.358 (range $39.535–$40.855).
- Shares sold: 89,716 on Feb 17; 93,743 on Feb 18; total ≈ 183,459 shares; approximate proceeds ≈ $7.36M.
- Shares owned after transaction: The filing does not attribute these shares as Elliott’s direct holdings; he disclaims beneficial ownership except for any indirect pecuniary interest.
- Footnotes: Reporter (Elliott) is a partner at Bessemer and states the sales were by the Bessemer Funds; he offers to provide a per-price breakdown on request. This report does not assert Elliott personally sold the shares.
- Timeliness: Reported Feb 19, 2026 covering Feb 17–18 trades — appears timely (filed within the Form 4 filing window).
Context
- These are institutional fund sales by Bessemer-managed vehicles, disclosed because Elliott is a partner with an indirect economic interest. Such sales reflect fund-level portfolio activity rather than a direct insider sale by an executive; they should be interpreted accordingly. Purchases generally carry stronger signals about insider conviction; this filing documents routine fund liquidation.
Insider Transaction Report
Form 4
Robinson Elliott
Director10% Owner
Transactions
- Sale
Class A Common Stock
[F1][F3]2026-02-17−0→ 0 total(indirect: See footnote) - Sale
Class A Common Stock
[F1][F2][F3]2026-02-18−0→ 0 total(indirect: See footnote)
Footnotes (3)
- [F1]On February 17, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 46,276 and 43,440 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $39.929. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]On February 18, 2026, BVP X and BVP X Inst sold 48,353 and 45,390 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.358. These shares were sold in multiple transactions at prices ranging from $39.535 to $40.855. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
Signature
/s/ Augie Wilkinson, Attorney-in-Fact|2026-02-19